These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9342486)

  • 41. The use of urine protein 1 as an indicator of renal tubular function in type I (insulin-dependent) diabetes.
    Ayatse JO; Wright JW
    Acta Med Hung; 1994; 50(1-2):99-107. PubMed ID: 7638047
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proteinuria is still useful for the screening and diagnosis of overt diabetic nephropathy.
    Zelmanovitz T; Gross JL; Oliveira J; de Azevedo MJ
    Diabetes Care; 1998 Jul; 21(7):1076-9. PubMed ID: 9653598
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Measurement of soluble thrombomodulin in sera from various clinical stages of diabetic nephropathy.
    Rinno H; Kuramoto T; Iijima T; Yagame M; Tomino Y
    J Clin Lab Anal; 1996; 10(3):119-24. PubMed ID: 8731497
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Urinary excretion of type IV collagen and laminin in the evaluation of nephropathy in NIDDM: comparison with urinary albumin and markers of tubular dysfunction and/or damage.
    Banu N; Hara H; Okamura M; Egusa G; Yamakido M
    Diabetes Res Clin Pract; 1995 Jul; 29(1):57-67. PubMed ID: 8593760
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Urinary enzymes as a marker of the preclinical stage of diabetic nephropathy].
    Dedov II; Mukhin NA; Pal'tsev MA; Delektorskaia LN; Shestakova MV
    Ter Arkh; 1989; 61(12):73-6. PubMed ID: 2629151
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Kidney lesions in non-insulin dependent diabetes mellitus].
    Georgadze ZO; Balabolkin MI; Mamaeva GG; Liudina LI; Mishchenko BP; Arbuzova MI
    Klin Med (Mosk); 1995; 73(6):21-2. PubMed ID: 8691771
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Evaluation of a new immunoturbidimetry technique for measuring microalbuminuria].
    Gigli G; Altomonte F; Bocca B; Colombano M; De Grandi R; Ponte M; Triolo A
    Boll Soc Ital Biol Sper; 1991 Mar; 67(3):273-8. PubMed ID: 1930902
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of urinary γ-glutamyltransferase and alkaline phosphatase for diagnosis of diabetic nephropathy.
    De Carvalho JA; Piva SJ; Hausen BS; Bochi GV; Kaefer M; Coelho AC; Duarte MM; Moresco RN
    Clin Chim Acta; 2011 Jul; 412(15-16):1407-11. PubMed ID: 21527256
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Characteristics of the proteinuria in diabetic nephropathy].
    Astrug A; Genov D
    Vutr Boles; 1978; 17(2):72-9. PubMed ID: 77585
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Developmental phases and diagnostic criteria in diabetic nephropathy].
    Duława J
    Pol Tyg Lek; 1990 Oct 1-8; 45(40-41):807-9. PubMed ID: 2096373
    [No Abstract]   [Full Text] [Related]  

  • 51. Analysis of urinary protein in diabetics; its clinical implications as a predictor of nephropathy.
    Suenaga K
    Nihon Jinzo Gakkai Shi; 1991 Jan; 33(1):43-52. PubMed ID: 2038131
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alpha-1 microglobulin: a marker for early detection of tubular disorders in diabetic nephropathy.
    Shore N; Khurshid R; Saleem M
    J Ayub Med Coll Abbottabad; 2010; 22(4):53-5. PubMed ID: 22455261
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Determination of albuminuria in type 1 and type 2 diabetic patients with microproteinuria and overt nephropathy. Comparative evaluation between a radial immunodiffusion procedure and a highly sensitive radioimmunoassay.
    Fioravanti M; Solerte SB; Patti AL; Bacchella L; Zanoletti MG; Mancin D; Schifino N; Aprile C; Ferrari E
    Ric Clin Lab; 1987; 17(2):171-9. PubMed ID: 3114868
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human urinary intestinal alkaline phosphatase as an indicator of S3-segment-specific alterations in incipient diabetic nephropathy.
    Nuyts GD; Yaqoob M; Nouwen EJ; Patrick AW; McClelland P; MacFarlane IA; Bell GM; De Broe ME
    Nephrol Dial Transplant; 1994; 9(4):377-81. PubMed ID: 8084450
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A further investigation on a MALDI-based method for evaluation of markers of renal damage.
    Lapolla A; Molin L; Sechi A; Cosma C; Ragazzi E; Seraglia R; Traldi P
    J Mass Spectrom; 2009 Dec; 44(12):1754-60. PubMed ID: 19852035
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of exercise on hemodynamics and urinary protein excretion in patients with early-stage diabetic nephropathy.
    Kanauchi M; Ishii K; Nishiura K; Dohi K
    Nihon Jinzo Gakkai Shi; 1994 Aug; 36(8):928-33. PubMed ID: 7933669
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantitative assessment of urinary protein and enzyme excretion--a diagnostic programme for the detection of renal involvement in type I diabetes mellitus.
    Kordonouri O; Jörres A; Müller C; Enders I; Gahl GM; Weber B
    Scand J Clin Lab Invest; 1992 Dec; 52(8):781-90. PubMed ID: 1488617
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Early detection of nephroangiopathy in patients with diabetes mellitus and approaches to its correction].
    Spesivtseva VG; Mamaeva GG; Starosel'tseva LK; Kozlova EG
    Ter Arkh; 1989; 61(6):67-9. PubMed ID: 2799719
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Incipient nephropathy in type 1 (insulin-dependent) diabetes.
    Mathiesen ER; Oxenbøll B; Johansen K; Svendsen PA; Deckert T
    Diabetologia; 1984 Jun; 26(6):406-10. PubMed ID: 6468791
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low molecular weight proteinuria in insulin-dependent diabetes.
    Fletcher JA; Crockson RA; Mijovic C; Cooper EH; Bradwell AR; Barnett AH
    Diabetes Res; 1986 May; 3(4):203-6. PubMed ID: 3742942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.